Aluminum
Compare Stocks
2 / 10Stock Comparison
CSTM vs CRS
Revenue, margins, valuation, and 5-year total return — side by side.
Manufacturing - Metal Fabrication
CSTM vs CRS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Aluminum | Manufacturing - Metal Fabrication |
| Market Cap | $4.48B | $22.11B |
| Revenue (TTM) | $9.29B | $3.03B |
| Net Income (TTM) | $441M | $479M |
| Gross Margin | 13.1% | 29.7% |
| Operating Margin | 6.8% | 21.3% |
| Forward P/E | 10.2x | 40.9x |
| Total Debt | $1.94B | $738M |
| Cash & Equiv. | $120M | $316M |
CSTM vs CRS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Constellium SE (CSTM) | 100 | 412.7 | +312.7% |
| Carpenter Technolog… (CRS) | 100 | 1830.8 | +1730.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CSTM vs CRS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CSTM is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 1 yrs, beta 1.85
- Rev growth 15.2%, EPS growth 418.9%, 3Y rev CAGR -0.3%
- 15.2% revenue growth vs CRS's 4.3%
CRS carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 13.9% 10Y total return vs CSTM's 5.0%
- Lower volatility, beta 1.37, Low D/E 39.1%, current ratio 3.65x
- Beta 1.37, yield 0.2%, current ratio 3.65x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 15.2% revenue growth vs CRS's 4.3% | |
| Value | Lower P/E (10.2x vs 40.9x) | |
| Quality / Margins | 15.8% margin vs CSTM's 4.7% | |
| Stability / Safety | Beta 1.37 vs CSTM's 1.85, lower leverage | |
| Dividends | 0.2% yield; the other pay no meaningful dividend | |
| Momentum (1Y) | +205.2% vs CRS's +113.2% | |
| Efficiency (ROA) | 13.6% ROA vs CSTM's 8.0%, ROIC 17.5% vs 13.4% |
CSTM vs CRS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CSTM vs CRS — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CRS leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CSTM is the larger business by revenue, generating $9.3B annually — 3.1x CRS's $3.0B. CRS is the more profitable business, keeping 15.8% of every revenue dollar as net income compared to CSTM's 4.7%. On growth, CSTM holds the edge at +14.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $9.3B | $3.0B |
| EBITDAEarnings before interest/tax | $978M | $791M |
| Net IncomeAfter-tax profit | $441M | $479M |
| Free Cash FlowCash after capex | $175M | $407M |
| Gross MarginGross profit ÷ Revenue | +13.1% | +29.7% |
| Operating MarginEBIT ÷ Revenue | +6.8% | +21.3% |
| Net MarginNet income ÷ Revenue | +4.7% | +15.8% |
| FCF MarginFCF ÷ Revenue | +1.9% | +13.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +14.9% | +11.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +4.3% | +47.3% |
Valuation Metrics
CSTM leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 17.1x trailing earnings, CSTM trades at a 71% valuation discount to CRS's 60.0x P/E. On an enterprise value basis, CSTM's 7.8x EV/EBITDA is more attractive than CRS's 34.1x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $4.5B | $22.1B |
| Enterprise ValueMkt cap + debt − cash | $6.3B | $22.5B |
| Trailing P/EPrice ÷ TTM EPS | 17.12x | 59.96x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.19x | 40.91x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.28x |
| EV / EBITDAEnterprise value multiple | 7.83x | 34.08x |
| Price / SalesMarket cap ÷ Revenue | 0.53x | 7.68x |
| Price / BookPrice ÷ Book value/share | 4.81x | 11.95x |
| Price / FCFMarket cap ÷ FCF | 28.16x | 77.27x |
Profitability & Efficiency
CRS leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
CSTM delivers a 46.9% return on equity — every $100 of shareholder capital generates $47 in annual profit, vs $24 for CRS. CRS carries lower financial leverage with a 0.39x debt-to-equity ratio, signaling a more conservative balance sheet compared to CSTM's 2.00x. On the Piotroski fundamental quality scale (0–9), CSTM scores 8/9 vs CRS's 7/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +46.9% | +24.4% |
| ROA (TTM)Return on assets | +8.0% | +13.6% |
| ROICReturn on invested capital | +13.4% | +17.5% |
| ROCEReturn on capital employed | +13.9% | +17.9% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 7 |
| Debt / EquityFinancial leverage | 2.00x | 0.39x |
| Net DebtTotal debt minus cash | $1.8B | $423M |
| Cash & Equiv.Liquid assets | $120M | $316M |
| Total DebtShort + long-term debt | $1.9B | $738M |
| Interest CoverageEBIT ÷ Interest expense | 7.26x | 13.82x |
Total Returns (Dividends Reinvested)
CRS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CRS five years ago would be worth $108,568 today (with dividends reinvested), compared to $19,144 for CSTM. Over the past 12 months, CSTM leads with a +205.2% total return vs CRS's +113.2%. The 3-year compound annual growth rate (CAGR) favors CRS at 106.4% vs CSTM's 28.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +66.3% | +31.6% |
| 1-Year ReturnPast 12 months | +205.2% | +113.2% |
| 3-Year ReturnCumulative with dividends | +112.6% | +779.4% |
| 5-Year ReturnCumulative with dividends | +91.4% | +985.7% |
| 10-Year ReturnCumulative with dividends | +503.1% | +1387.4% |
| CAGR (3Y)Annualised 3-year return | +28.6% | +106.4% |
Risk & Volatility
Evenly matched — CSTM and CRS each lead in 1 of 2 comparable metrics.
Risk & Volatility
CRS is the less volatile stock with a 1.37 beta — it tends to amplify market swings less than CSTM's 1.85 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CSTM currently trades 97.1% from its 52-week high vs CRS's 93.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.87x | 1.34x |
| 52-Week HighHighest price in past year | $33.84 | $475.69 |
| 52-Week LowLowest price in past year | $10.71 | $204.47 |
| % of 52W HighCurrent price vs 52-week peak | +97.1% | +93.5% |
| RSI (14)Momentum oscillator 0–100 | 66.9 | 63.6 |
| Avg Volume (50D)Average daily shares traded | 2.3M | 695K |
Analyst Outlook
CSTM leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates CSTM as "Buy" and CRS as "Buy". Consensus price targets imply 10.3% upside for CSTM (target: $36) vs 4.7% for CRS (target: $466). CRS is the only dividend payer here at 0.18% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $36.25 | $465.80 |
| # AnalystsCovering analysts | 17 | 21 |
| Dividend YieldAnnual dividend ÷ price | — | +0.2% |
| Dividend StreakConsecutive years of raises | 1 | 0 |
| Dividend / ShareAnnual DPS | — | $0.79 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.6% | +0.5% |
CRS leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CSTM leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.
CSTM vs CRS: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CSTM or CRS a better buy right now?
For growth investors, Constellium SE (CSTM) is the stronger pick with 15.
2% revenue growth year-over-year, versus 4. 3% for Carpenter Technology Corporation (CRS). Constellium SE (CSTM) offers the better valuation at 17. 1x trailing P/E (10. 2x forward), making it the more compelling value choice. Analysts rate Constellium SE (CSTM) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CSTM or CRS?
On trailing P/E, Constellium SE (CSTM) is the cheapest at 17.
1x versus Carpenter Technology Corporation at 60. 0x. On forward P/E, Constellium SE is actually cheaper at 10. 2x.
03Which is the better long-term investment — CSTM or CRS?
Over the past 5 years, Carpenter Technology Corporation (CRS) delivered a total return of +985.
7%, compared to +91. 4% for Constellium SE (CSTM). Over 10 years, the gap is even starker: CRS returned +1331% versus CSTM's +521. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CSTM or CRS?
By beta (market sensitivity over 5 years), Carpenter Technology Corporation (CRS) is the lower-risk stock at 1.
34β versus Constellium SE's 1. 87β — meaning CSTM is approximately 39% more volatile than CRS relative to the S&P 500. On balance sheet safety, Carpenter Technology Corporation (CRS) carries a lower debt/equity ratio of 39% versus 2% for Constellium SE — giving it more financial flexibility in a downturn.
05Which is growing faster — CSTM or CRS?
By revenue growth (latest reported year), Constellium SE (CSTM) is pulling ahead at 15.
2% versus 4. 3% for Carpenter Technology Corporation (CRS). On earnings-per-share growth, the picture is similar: Constellium SE grew EPS 418. 9% year-over-year, compared to 100. 5% for Carpenter Technology Corporation. Over a 3-year CAGR, CRS leads at 16. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CSTM or CRS?
Carpenter Technology Corporation (CRS) is the more profitable company, earning 13.
1% net margin versus 3. 2% for Constellium SE — meaning it keeps 13. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CRS leads at 18. 1% versus 5. 6% for CSTM. At the gross margin level — before operating expenses — CRS leads at 26. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CSTM or CRS more undervalued right now?
On forward earnings alone, Constellium SE (CSTM) trades at 10.
2x forward P/E versus 40. 9x for Carpenter Technology Corporation — 30. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CSTM: 10. 3% to $36. 25.
08Which pays a better dividend — CSTM or CRS?
In this comparison, CRS (0.
2% yield) pays a dividend. CSTM does not pay a meaningful dividend and should not be held primarily for income.
09Is CSTM or CRS better for a retirement portfolio?
For long-horizon retirement investors, Carpenter Technology Corporation (CRS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1331% 10Y return).
Constellium SE (CSTM) carries a higher beta of 1. 87 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CRS: +1331%, CSTM: +521. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CSTM and CRS?
These companies operate in different sectors (CSTM (Basic Materials) and CRS (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CSTM is a small-cap high-growth stock; CRS is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.